ProMIS Neurosciences, Inc.
PMN
$10.57
$0.080.76%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -39.72M | -29.28M | -8.43M | -934.00K | 2.78M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 852.00K | -4.26M | -17.81M | -18.06M | -18.23M |
| Change in Net Operating Assets | 10.75M | 5.99M | 2.07M | -2.82M | -11.73M |
| Cash from Operations | -28.12M | -27.55M | -24.17M | -21.82M | -27.18M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -700.00 | -700.00 | -700.00 | -700.00 | -700.00 |
| Cash from Investing | -700.00 | -700.00 | -700.00 | -700.00 | -700.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 20.25M | 20.72M | 27.69M | 27.69M | 27.88M |
| Repurchase of Common Stock | -10.17M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 10.87M | 697.70K | -- | -- | -- |
| Cash from Financing | 20.94M | 21.41M | 27.69M | 27.69M | 27.88M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.17M | -6.14M | 3.52M | 5.87M | 693.00K |